Related Experiment Videos
[Study on structure change and hypermethylation of p16 gene in multiple myeloma]
1Department of Hematology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Objective:
To illustrate the role of structure and hypermethylation of p16 gene in the pathogenesis of multiple myeloma(MM).
Methods:
By using PCR-single strand conformation polymorphisms(PCR-SSCP) and methylation-specific PCR(MSP) techniques, the structure and hypermethylation status of p16 gene in MM cell lines and patients were analysed.
Results:
Homozygous deletion of p16 exon 2 was found in KM3 cells. The completely methylated p16 gene and hypermethylation of CPG island were observed in U266, LP1 cell lines and 55.56% of MM patients.
Conclusion:
Methylation of p16 gene is important in the pathogenesis of MM and may provide a new drug target for the treatment of MM.
Insights
Hypermethylation of the p16 gene is crucial in multiple myeloma (MM) development, showing significant presence in cell lines and patients. This finding suggests p16 methylation as a potential therapeutic target for MM.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Context:
- Multiple myeloma (MM) is a hematological malignancy.
- The p16 gene plays a role in cell cycle regulation and is frequently altered in cancers.
Purpose:
- To investigate the structural alterations and hypermethylation of the p16 gene in the pathogenesis of multiple myeloma (MM).
Summary:
- Utilized PCR-single strand conformation polymorphisms (PCR-SSCP) and methylation-specific PCR (MSP) to analyze p16 gene status in MM cell lines and patient samples.
- Observed homozygous deletion of p16 exon 2 in KM3 cells.
- Found complete methylation of the p16 gene and CpG island hypermethylation in U266, LP1 cell lines, and 55.56% of MM patients.
Impact:
- Demonstrates the significant role of p16 gene methylation in MM pathogenesis.
- Identifies p16 gene methylation as a potential novel therapeutic target for multiple myeloma treatment.